Vontobel continues multi-boutique expansion in North America
NEW YORK--(BUSINESS WIRE)--With growing demand from US and Canadian investors for systematic and fundamental…
4 years ago
Wire Stories
Seagen, Astellas and Merck Announce Results of Clinical Trial Investigating PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) and PADCEV as Monotherapy in First-Line Advanced Urothelial Cancer
– Results demonstrated a 64.5% confirmed objective response rate in patients treated with investigational combination…
4 years ago
AnHeart Therapeutics and NewG Lab Therapeutics Receive Orphan Drug Designation in Korea for Taletrectinib in ROS1-Positive Non-Small Cell Lung Cancer
NEW YORK & SEOUL, South Korea--(BUSINESS WIRE)--#BTD--AnHeart Therapeutics and NewG Lab Therapeutics, a subsidiary of…
4 years ago
Bacardi Announces New Leadership for Its Global Travel Retail Business
HAMILTON, Bermuda--(BUSINESS WIRE)--#BacardiLife--Bacardi announces a change at the top of its global travel retail business…
4 years ago
Vista Gold Corp. Provides Update on Strategic Process
DENVER--(BUSINESS WIRE)--Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista” or the “Company”) today announced…
4 years ago
LESSENGERS Demonstrates 800G QSFP-DD and 400G QSFP112 Optical Transceivers
BASEL, Switzerland--(BUSINESS WIRE)--LESSENGERS Inc. (“LESSENGERS”), an innovative optical interconnect solution provider, announced today, a live…
4 years ago
India Over The Counter Drug Market to Grow at 7.85% Through 2028 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "India Over The Counter Drug Market, By Product Type, By Route of Administration,…
4 years ago
J.P. Morgan to Acquire Renovite Technologies, Inc.
Acquisition of cloud-native payments technology firm to modernize infrastructure and create greater flexibility for the…
4 years ago
Announcement for “Innovation for Cool Earth Forum 9th Annual Meeting (ICEF2022)”
The international conference to discuss innovation, the key to solving global warming with experts from…
4 years ago
Cellusion and Celregen, a member of Fosun Pharma, Enter into Exclusive License Agreement of CLS001 for a Corneal Endothelial Cell Regenerative Therapy in the Greater China Region
Celregen Obtains the Exclusive Rights to Develop, Manufacturing and Commercialize CLS001 in Greater China Region;…
4 years ago